Trends in Long-term Cancer Survival in Cali, Colombia: 1998-2017

Overview

Journal Colomb Med (Cali)

Specialties General Medicine
Public Health

Date 2022 Dec 1

PMID 36452118

Authors

Luis Eduardo Bravo

Luz Stella Garcia

Paola Collazos

Jorge Holguin

Isabelle Soerjomataram

Adalberto Miranda-Filho

Affiliations

Soon will be listed here.

Abstract

Background: Population-based cancer survival is an indicator of the effectiveness of cancer services that reflects the survival of all cancer patients in the population, regardless of socioeconomic status and disease characteristics.

Aim: Provision of an up-to-date survival estimate of patients recorded within Cali Population Cancer Registry (RPCC) in 1998-2017. As a second objective, results will be compared with those reported by the CONCORD study for cancers prioritized by the current Ten-Year Cancer Control Plan of Colombia, 2012-2021.

Methods: Adult cancer cases (aged 15 to 99 years) for nine cancer types diagnosed between 1998 and 2017, with follow-up to 2018, were obtained from the RPCC. The 5-year age-standardized net survival estimates (NS) were estimated using the Pohar-Perme. The results for the period 1995- 2014 were compared with those reported by the CONCORD study for the following locations: stomach (C16), breast (C50), cervix (C53), prostate (C61), and lung (C33-34).

Results: Five-year survival estimates for breast and prostate cancers improved ten percentage points through 2007 (70.8 to 81.1 for breast and 79.9 to 90.2 for prostate) and remained stable during 2008-2017. For cervical cancer, survival estimates has remained stable for the last two decades at 53%. For stomach cancer and lung cancer, five-year NS was lower than 25% over the study period. For colorectal cancer, survival estimates increased from 37.9% in 1998-2002 to 54.8% in 2013-2017. Compared to previous 5-year survival estimates of cases diagnosed in 2010-2014, the estimates in this study are significantly higher than those obtained by CONCORD. Survival estimates of patients diagnosed in 1995-2009 showed no difference to CONCORD study.

Conclusions: Periodic update of vital status and date of last contact reduces bias in survival estimates in population-based cancer registries with passive follow-up.

Citing Articles

Impact of the universal health insurance benefits on cervical cancer mortality in Colombia.

Lewis A, Hernandez D, Garces-Palacio I, Soliman A BMC Health Serv Res. 2024; 24(1):693.

PMID: 38822370 PMC: 11143589. DOI: 10.1186/s12913-024-10979-0.

Survival of 48866 cancer patients: results from Nantong area, China.

Wang G, Xu H, Chen H, Chen Y, Ni Z, Fan L Front Oncol. 2023; 13:1244545.

PMID: 37637071 PMC: 10455932. DOI: 10.3389/fonc.2023.1244545.

References

Pinheiro P, Morris C, Liu L, Bungum T, Altekruse S . The impact of follow-up type and missed deaths on population-based cancer survival studies for Hispanics and Asians. J Natl Cancer Inst Monogr. 2014; 2014(49):210-7. PMC: 4841164. DOI: 10.1093/jncimonographs/lgu016. View

Munoz N, Bravo L . Epidemiology of cervical cancer in Colombia. Salud Publica Mex. 2015; 56(5):431-9. DOI: 10.21149/spm.v56i5.7368. View

Zahl P, Jorgensen K, Gotzsche P . Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer. 2013; 109(7):2014-9. PMC: 3790152. DOI: 10.1038/bjc.2013.427. View

Bravo L, Garcia L, Collazos P, Carrascal E, Ardila E, Millan E . Cancer epidemiology in Cali, 60 years of experience. Colomb Med (Cali). 2022; 53(1):e2005050. PMC: 9651077. DOI: 10.25100/cm.v53i1.5050. View

Atkin W, Wooldrage K, Parkin D, Kralj-Hans I, Macrae E, Shah U . Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet. 2017; 389(10076):1299-1311. PMC: 6168937. DOI: 10.1016/S0140-6736(17)30396-3. View

Frech S, Morton Doherty R, Lesmes Duque M, Ramirez O, Pomata A, Samudio A . C/Can City Engagement Process: An Implementation Framework for Strengthening Cancer Care in Cities in Low- and Middle-Income Countries. JCO Glob Oncol. 2021; 7:901-916. PMC: 8457859. DOI: 10.1200/GO.20.00606. View

Bravo L, Garcia L, Carrascal E, Rubiano J . Burden of breast cancer in Cali, Colombia: 1962-2012. Salud Publica Mex. 2015; 56(5):448-56. PMC: 7282241. DOI: 10.21149/spm.v56i5.7370. View

Pohar Perme M, Stare J, Esteve J . On estimation in relative survival. Biometrics. 2011; 68(1):113-20. DOI: 10.1111/j.1541-0420.2011.01640.x. View

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M . Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125):1023-1075. PMC: 5879496. DOI: 10.1016/S0140-6736(17)33326-3. View

10.

Kalager M, Adami H, Lagergren P, Steindorf K, Dickman P . Cancer outcomes research-a European challenge: measures of the cancer burden. Mol Oncol. 2021; 15(12):3225-3241. PMC: 8637567. DOI: 10.1002/1878-0261.13012. View

11.

Murcia E, Aguilera J, Wiesner C, Pardo C . Oncology services supply in Colombia. Colomb Med (Cali). 2018; 49(1):89-96. PMC: 6018814. DOI: 10.25100/cm.v49i1.3620. View

12.

Bravo L, Arboleda O, Ramirez O, Duran A, Lesmes M, Rendler-Garcia M . Cali, Colombia, Key learning City C/Can 2025: City Cancer Challenge. Colomb Med (Cali). 2017; 48(2):39-40. PMC: 5625564. DOI: 10.25100/cm.v48i2.3203. View

13.

Bravo L, Garcia L, Collazos P, Carrascal E, Ramirez O, Collazos T . Reliable information for cancer control in Cali, Colombia. Colomb Med (Cali). 2018; 49(1):23-34. PMC: 6018818. DOI: 10.25100/cm.v49i1.3689. View

14.

Potosky A, Feuer E, Levin D . Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev. 2001; 23(1):181-6. DOI: 10.1093/oxfordjournals.epirev.a000787. View

15.

Garcia L, Bravo L, Collazos P, Ramirez O, Carrascal E, Nunez M . Cali cancer registry methods. Colomb Med (Cali). 2018; 49(1):109-120. PMC: 6018820. DOI: 10.25100/cm.v49i1.3853. View

16.

Bravo L, Garcia L, Collazos P . Cancer survival in Cali, Colombia: A population-based study, 1995-2004. Colomb Med (Cali). 2014; 45(3):110-6. PMC: 4225787. View

17.

Corazziari I, Quinn M, Capocaccia R . Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004; 40(15):2307-16. DOI: 10.1016/j.ejca.2004.07.002. View

18.

Murillo R . [Cervical cancer control in Colombia: achievements and challenges of cytology based programs]. Biomedica. 2009; 28(4):467-70. View

19.

Bravo L, Collazos T, Collazos P, Garcia L, Correa P . Trends of cancer incidence and mortality in Cali, Colombia. 50 years experience. Colomb Med (Cali). 2014; 43(4):246-55. PMC: 4001963. View

20.

Allemani C, Weir H, Carreira H, Harewood R, Spika D, Wang X . Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2014; 385(9972):977-1010. PMC: 4588097. DOI: 10.1016/S0140-6736(14)62038-9. View